Adagio Medical, Inc., developer of the iCLAS™ technology, the company's ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias, announced updates to its ongoing cryoablation study for...
Adagio Medical, Inc., developer of the iCLAS™ technology, the company's ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias, announced updates to its ongoing cryoablation study for...
Adagio Medical, Inc., developer...